Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label phase II study

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 2033-2033 ◽  
Author(s):  
L. E. Abrey ◽  
P. Wen ◽  
R. Govindan ◽  
H. Reimers ◽  
J. R. Rigas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)

Lung Cancer ◽  
2017 ◽  
Vol 104 ◽  
pp. 126-130 ◽  
Author(s):  
Mark M. Awad ◽  
Quincy S-C Chu ◽  
Leena Gandhi ◽  
Joe J. Stephenson ◽  
Ramaswamy Govindan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase ◽  
Bi 2536

Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study

2013 ◽  
Vol 125 (15-16) ◽  
pp. 481-486 ◽  
Author(s):  
Marco Ronald Hassler ◽  
Wolfgang Pfeifer ◽  
Thomas Hendrik Knocke-Abulesz ◽  
Klaus Geissler ◽  
Gabriele Altorjai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Whole Brain Radiotherapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Brain Radiotherapy
Sign in / Sign up

Export Citation Format

Share Document